These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 34463711)

  • 1. Re-evaluation of nailfold capillaroscopy in discriminating primary from secondary Raynaud's phenomenon and in predicting systemic sclerosis: a randomised observational prospective cohort study.
    Amaral MC; Paula FS; Caetano J; Ames PR; Alves JD
    Expert Rev Clin Immunol; 2024 Jun; 20(6):665-672. PubMed ID: 38465507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capillaroscopic analysis of the microvascular status in mixed versus undifferentiated connective tissue disease.
    Pizzorni C; Ferrari G; Schenone C; Hysa E; Carmisciano L; Gotelli E; Pacini G; Sulli A; Paolino S; Smith V; Cutolo M
    Microvasc Res; 2022 Jul; 142():104367. PubMed ID: 35364109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early systemic sclerosis: short-term disease evolution and factors predicting the development of new manifestations of organ involvement.
    Valentini G; Vettori S; Cuomo G; Iudici M; D'Abrosca V; Capocotta D; Del Genio G; Santoriello C; Cozzolino D
    Arthritis Res Ther; 2012 Aug; 14(4):R188. PubMed ID: 22901779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between nailfold capillary aberrations and autoantibodies in children and adults with Raynaud's phenomenon.
    Mueller M; Gschwandtner ME; Emminger W; Kiener H; Schnaubelt S; Giurgea GA; Ristl R; Perkmann T; Koppensteiner R; Schlager O
    RMD Open; 2023 Mar; 9(1):. PubMed ID: 36972928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the use of nail cosmetics interfere with the reporting of nailfold capillaroscopy?
    Shenavandeh S
    Clin Rheumatol; 2023 May; 42(5):1307-1313. PubMed ID: 36624179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Nailfold Capillaroscopy in Evaluating Patients with Interstitial Lung Disease Related to Connective Tissue Disease.
    Venetsanopoulou AI; Goules AV; Vlachoyiannopoulos PG; Drosos AA; Tzioufas AG; Voulgari PV
    Mediterr J Rheumatol; 2023 Dec; 34(4):588-591. PubMed ID: 38282947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-Reported Systemic Sclerosis-Related Symptoms Are More Prevalent in Subjects with Raynaud's Phenomenon in the Lifelines Population: Focus on Pulmonary Complications.
    van de Zande SC; Abdulle AE; Al-Adwi Y; Stel A; de Leeuw K; Brouwer E; Arends S; Gan CT; van Goor H; Mulder DJ
    Diagnostics (Basel); 2023 Jun; 13(13):. PubMed ID: 37443554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric Primary Raynaud's Phenomenon: A Comprehensive Cardiovascular Analysis.
    Özpınar Ş; Bornaun H; Sönmez HE; Doğan S; Sönmez S; Harman H
    Pediatr Cardiol; 2024 May; ():. PubMed ID: 38739175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Capillaroscopy, microangiopathy, and HIV. Descriptive study of capillaroscopy findings in HIV positive patients].
    Verdejo-Muñoz G; Gálvez-Barrón C; Gracia Tello B; Gamarra Calvo S; Sanjoaquín Conde I; Catena A; Blanco Ramos JR
    An Sist Sanit Navar; 2022 Dec; 45(3):. PubMed ID: 36468584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges in Performing Nail-Fold Capillaroscopy during COVID-19.
    Jakhar D; Grover C
    Skin Appendage Disord; 2021 Apr; 7(3):246-247. PubMed ID: 34046435
    [No Abstract]   [Full Text] [Related]  

  • 11. Do We Have Good Activity Indices in Systemic Sclerosis?
    Groseanu L; Petrescu S; Balanescu A; Bojinca V; Opris-Belinski D; Berghea F; Mazilu D; Saulescu I; Borangiu A; Daia-Iliescu S; Constantinescu C; Cobilinschi C; Abobului M; Negru MM; Ionescu R
    Curr Rheumatol Rev; 2022; 18(1):39-47. PubMed ID: 34517805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of microvascular changes in systemic sclerosis and other rheumatic diseases.
    Cutolo M; Smith V
    Nat Rev Rheumatol; 2021 Nov; 17(11):665-677. PubMed ID: 34561652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Systematic Review of Aminaphtone from Pathophysiology to Clinical Applications: Focus on New Rheumatological Acquisitions.
    Gotelli E; Soldano S; Hysa E; Pacini G; Pizzorni C; Paolino S; Cutolo M; Sulli A
    Pharmaceuticals (Basel); 2023 Apr; 16(4):. PubMed ID: 37111326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Causes of Raynaud's phenomenon and the predictive laboratory and capillaroscopy features for the evolution to a definite connective tissue disease.
    Shenavandeh S; Ajri M; Hamidi S
    Rheumatology (Oxford); 2022 May; 61(5):1975-1985. PubMed ID: 34463711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scleroderma pattern of nailfold capillary changes as predictive value for the development of a connective tissue disease: a follow-up study of 3,029 patients with primary Raynaud's phenomenon.
    Pavlov-Dolijanovic S; Damjanov NS; Stojanovic RM; Vujasinovic Stupar NZ; Stanisavljevic DM
    Rheumatol Int; 2012 Oct; 32(10):3039-45. PubMed ID: 21901350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Value of Nailfold Capillaroscopy in the Classification and Differential Diagnosis of Raynaud's Phenomenon in Rheumatology.
    Lambova SN
    Curr Rheumatol Rev; 2024; 20(2):108-114. PubMed ID: 37691224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of Scleroderma pattern at nail fold capillaroscopy valuable in the exclusion of Scleroderma in unselected patients with Raynaud's Phenomenon.
    Bissell LA; Abignano G; Emery P; Del Galdo F; Buch MH
    BMC Musculoskelet Disord; 2016 Aug; 17(1):342. PubMed ID: 27526772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raynaud's phenomenon.
    Hughes M; Herrick AL
    Best Pract Res Clin Rheumatol; 2016 Feb; 30(1):112-32. PubMed ID: 27421220
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.